Retrieve available abstracts of 75 articles: HTML format
Single Articles
June 2025
MINAMI S, Miyoshi N, Fujino S, Yasui M, et al Role of the Circadian Clock Gene DEC1 in Chemosensitivity and Apoptosis in
Colorectal Cancer.
Anticancer Res. 2025;45:2309-2328. PubMedAbstract available
YU X, Tsunedomi R, Hazama S, Nakagami Y, et al Immunogenicity of Neoantigens in Colorectal Cancer: Potential Influence of Tumor
Mutation Burden, Stages, and Metastasis.
Anticancer Res. 2025;45:2385-2399. PubMedAbstract available
ANDO Y, Orito H, Mizuno T, Katsuno H, et al Effect of a Biweekly Dosing Schedule on Severe Neutropenia Induced by
Trifluridine/Tipiracil in Colorectal Cancer.
Anticancer Res. 2025;45:2587-2594. PubMedAbstract available
ESKELINEN M, Selander T, Guimaraes DP, Kaarniranta K, et al Four Different Artificial Intelligence Models Versus Logistic Regression to
Enhance the Diagnostic Accuracy of Fecal Immunochemical Test in the Detection of
Colorectal Carcinoma in a Screening Setting.
Anticancer Res. 2025;45:2477-2491. PubMedAbstract available
KODAMA H, Yamaguchi T, Kameishi S, Kadono T, et al Tumor Budding Grade and T Stage as Recurrence Predictors of High-risk Stage II
Colorectal Cancer.
Anticancer Res. 2025;45:2619-2628. PubMedAbstract available
KATAOKA A, Kawasaki T, Kaira K, Hirano Y, et al Pathological Investigation of Grasping-related Mesenteric Injury During
Laparoscopic Colorectal Cancer Resection.
Anticancer Res. 2025;45:2493-2499. PubMedAbstract available
ASANO Y, Han Q, Li S, Mizuta K, et al Selective Synergy of Ivermectin Combined With Recombinant Methioninase Against
Colon-Cancer Cells in Contrast to Normal Fibroblasts.
Anticancer Res. 2025;45:2257-2263. PubMedAbstract available
KOBAYASHI Y, Takano Y, Matsukida S, Takishima T, et al Prognostic Nutritional Index Is the Key Prognostic Factor in Elderly Patients
With Colorectal Cancer.
Anticancer Res. 2025;45:2595-2603. PubMedAbstract available
May 2025
HWANG HH, Yoo JS, Je JH, Lee HC, et al SH003 Inhibits Proliferation and Induces Apoptosis in Colon Cancer Through the
RTK-STAT3 Pathway.
Anticancer Res. 2025;45:1965-1980. PubMedAbstract available
IZUTANI Y, Ogino T, Fujii M, Sekido Y, et al Appendectomy Mitigates Ulcerative Colitis Activity and Delays Colorectal Cancer
Onset: A Retrospective Cohort Study.
Anticancer Res. 2025;45:2205-2214. PubMedAbstract available
April 2025
OKEMOTO D, Yamaguchi T, Sugino K, Matsuo N, et al Chemotherapy Efficacy in Patients With Colorectal Cancer Experiencing Early
Recurrence During or After Adjuvant Chemotherapy.
Anticancer Res. 2025;45:1695-1705. PubMedAbstract available
YUEH TC, Chen YJ, Mong MC, Ke TW, et al The Contribution of Interleukin-12A and Interleukin-12B Genotypes to Colorectal
Cancer in Taiwan.
Anticancer Res. 2025;45:1501-1512. PubMedAbstract available
NII T, Yoshimi T, Tanito K, Hijii S, et al Inflammation-triggering Engineered Macrophages (MacTriggers) Are Promising
Cell-based Therapeutic Avenues for Chemoresistant Solid Tumors.
Anticancer Res. 2025;45:1395-1405. PubMedAbstract available
SUGIMOTO K, Irie T, Momose H, Kochi S, et al Circulating Tumor DNA Methylation Is a Biomarker of Poor Recurrence-free Survival
in Locally-Advanced Rectal Cancer.
Anticancer Res. 2025;45:1559-1573. PubMedAbstract available
March 2025
TERAISHI F, Yoshida Y, Shoji R, Kanaya N, et al Short-term Safety of Robot-assisted Rectal Surgery in Patients Aged >/=75 Years: A
Single-center Retrospective Study.
Anticancer Res. 2025;45:1291-1299. PubMedAbstract available
WEISS TS, Buechler C Proprotein Convertase Subtilisin/Kexin Type 9 Induction in Hypercholesterinemic
Patients With Primary and Metastatic Liver Tumors.
Anticancer Res. 2025;45:1171-1180. PubMedAbstract available
SHOJI R, Teraishi F, Kondo Y, Yoshida Y, et al Tailoring Neoadjuvant Therapy for Rectal Cancer: A Single-center Study of Local
Recurrence Patterns.
Anticancer Res. 2025;45:1261-1271. PubMedAbstract available
GOTO K, Ryu S, Imaizumi Y, Iwauchi S, et al Urethral Visualization Using Near-infrared Light Observation During
Transanal/Perineal Total Mesorectal Excision.
Anticancer Res. 2025;45:1241-1249. PubMedAbstract available
SUGIYAMA M, Kasagi Y, Yokomizo R, Terashi M, et al Oncologic Relevance and Anal Preservation Potential of Transanal Total Mesorectal
Excision for Rectal Cancer Invading Adjacent Organs.
Anticancer Res. 2025;45:1233-1239. PubMedAbstract available
February 2025
DREVS J, Malhotra MS, Sahinbas H, Iliopoulos A, et al Adjusting Treatment Strategies Using Circulating Tumor Cells: Preliminary Results
on Metastatic Colorectal Cancer.
Anticancer Res. 2025;45:491-502. PubMedAbstract available
YANG IJ, Kim DH, Lee KH, Kim JY, et al Safety and Survival Benefit of Adjuvant Chemotherapy for Elderly Patients With
Stage II/III Colon Cancer.
Anticancer Res. 2025;45:797-809. PubMedAbstract available
TAKISHIMA T, Kobayashi Y, Matsukida S, Kai W, et al Negative Impact of Low Serum Cholinesterase on Short- and Long-term Outcomes in
Elderly Patients Undergoing Scheduled Surgery for Colorectal Cancer.
Anticancer Res. 2025;45:743-750. PubMedAbstract available
January 2025
KAWAMURA H, Imaizumi T, Miyakawa T, Nakao E, et al Development of a Prognostic Model for Stage IV Colorectal Cancer Using Metastatic
Patterns.
Anticancer Res. 2025;45:341-350. PubMedAbstract available
ZHANG Y, Li X, Li S, Yang Z, et al Alternating Oxaliplatin and Irinotecan Chemotherapy Combined With Capecitabine
and Bevacizumab for Microsatellite-stable Stage IV Metastatic Colon Cancer With a
BRAF V600E Mutation: Two Case Reports Indicating Survival Improvement over
Standard Therap
Anticancer Res. 2025;45:399-404. PubMedAbstract available
KASUGA SO, Nozawa H, Ishihara S Changes in Mesorectal CT Values and Therapeutic Effect of Preoperative
Chemoradiotherapy in Rectal Cancer.
Anticancer Res. 2025;45:359-367. PubMedAbstract available
ESKELINEN M, Selander T, Guimaraes DP, Kaarniranta K, et al Artificial Intelligence Models Could Enhance the Diagnostic Accuracy (DA) of
Fecal Immunochemical Test (FIT) in the Detection of Colorectal Adenoma in a
Screening Setting.
Anticancer Res. 2025;45:267-275. PubMedAbstract available
TSAI YY, Ke TW, Huang CH, Chen TW, et al Prognostic Relevance of Immunosuppressive CD155/TIGIT Signaling in Locally
Advanced Rectal Cancer Patients With Neoadjuvant Chemoradiotherapy.
Anticancer Res. 2025;45:323-333. PubMedAbstract available
December 2024
KIM HB, Choi WY, Kim SH, Lee HJ, et al GNAO1: A Novel Tumor Suppressor Gene in Colorectal Cancer Pathogenesis.
Anticancer Res. 2024;44:5425-5433. PubMedAbstract available
SHIBUTANI M, Kashiwagi S, Tanda H, Seki Y, et al Prognostic Significance of Innovative Inflammation-nutrition Biomarker Score in
Patients With Colorectal Cancer.
Anticancer Res. 2024;44:5559-5567. PubMedAbstract available
SHIN H, Kim Y, Lee Y, Kim J, et al Chlorhexidine Dihydrochloride Shows Anti-tumor Effects in Desmoid Tumors and
Colorectal Cancer.
Anticancer Res. 2024;44:5435-5443. PubMedAbstract available
LEE Y, Kim Y, Shin H, Ryu YC, et al Anti-tumor Effects of Idarubicin Hydrochloride in Desmoid Tumors.
Anticancer Res. 2024;44:5313-5322. PubMedAbstract available
November 2024
ZADOROZNYJ A, Karam E, Michot N, Thiery J, et al Clinical and Oncological Impact of a Protective Ileostomy in Rectal Cancer
Patients Undergoing Adjuvant Chemotherapy.
Anticancer Res. 2024;44:4995-5005. PubMedAbstract available
NGUYEN MLT, Pham C, Nguyen TS, Nham PLT, et al Single-agent Adavosertib Shows Anticancer Effects Against Colorectal Cancer
Cells.
Anticancer Res. 2024;44:4941-4949. PubMedAbstract available
YASUI C, Kono Y, Ishiguro R, Yagyu T, et al New Treatment Modalities for Colorectal Cancer Through Simultaneous Suppression
of FSP1 and GPX4.
Anticancer Res. 2024;44:4905-4914. PubMedAbstract available
SUNG YN, Kim Y, Datuin AT, Jang I, et al Routine Elastic Staining Helps Detection of Vascular Invasion in Colorectal
Cancer: A Comprehensive Analysis of T3 or Higher Tumors Without Lymph Node
Metastasis.
Anticancer Res. 2024;44:5059-5065. PubMedAbstract available
October 2024
UNRUG-BIELAWSKA K, Earnshaw D, Cybulska-Lubak M, Kaniuga E, et al Therapeutic Responses to Two New SN-38 Derivatives in Colorectal Cancer
Patient-Derived Xenografts and Respective 3D In Vitro Cultures.
Anticancer Res. 2024;44:4219-4224. PubMedAbstract available
RUBIO CA, Vieth M, Lang-Schwarz C Nondysplastic Colon Crypts Intercalated in Tubular Adenomas Support Field
Cancerization.
Anticancer Res. 2024;44:4371-4377. PubMedAbstract available
HOSIK J, Hosikova B, Kolarova H, Bajgar R, et al 5,10,15,20-Tetrakis(4-sulfonatophenyl)porphyrin Zinc and Chloro-aluminum
Phthalocyanine Disulfonate in Photodynamic Therapy of Colorectal Adenocarcinoma
In Vitro.
Anticancer Res. 2024;44:4339-4346. PubMedAbstract available
VIRGILIO E, Salvemini C, Treglia MG, Thai E, et al Hotspots of Anal Cancer Screening in a High-risk Population: A Clinical Study on
Free Provision, Best Method, Self-sampling, and Independent Risk Factors.
Anticancer Res. 2024;44:4465-4481. PubMedAbstract available
September 2024
HOSOKAWA A, Tamura H, Ichihara A, Imamura N, et al Pathological Complete Response to Liver Metastasis With Pembrolizumab in a
Previously Treated Patient With Microsatellite Instability-high Colorectal
Cancer.
Anticancer Res. 2024;44:4119-4125. PubMedAbstract available
SHIRAISHI T, Yamaguchi A, Shibasaki Y, Osone K, et al Risk Factors of Poor Outcomes After Colorectal Cancer Surgery for Patients With
Severe Comorbidities.
Anticancer Res. 2024;44:4073-4083. PubMedAbstract available
COZZANI F, Ricchiuto M, Virgilio E, Viani L, et al The Controlling Nutritional Status (CONUT) Score Predicts Post-operatory Risks
and Prognosis in Patients With Surgically Treated Colon Cancer: A Retrospective
Study.
Anticancer Res. 2024;44:3955-3964. PubMedAbstract available
JINNO T, Yamaguchi J, Ogura A, Kokuryo T, et al Loss of Trefoil Factor 1 Accelerates the Immune Response to Colorectal Cancer.
Anticancer Res. 2024;44:3757-3769. PubMedAbstract available
FUKUSHIMA G, Sato E, Udo R, Tago T, et al Stromal CD4 (+) T Cell Subsets Mediate Antitumor Cytotoxic Immune Responses in
Human Colorectal Carcinoma.
Anticancer Res. 2024;44:3899-3906. PubMedAbstract available
KAYANO H, Mamuro N, Kamei Y, Ogimi T, et al Risk Factors Associated With Perioperative Skeletal Muscle Loss in Patients With
Colorectal Cancer.
Anticancer Res. 2024;44:4019-4029. PubMedAbstract available
TAKEDA K, Kikuchi Y, Sawada YU, Kumamoto T, et al Simultaneously Detected Liver and Lung Metastases from Colorectal Carcinoma: A
Potential Treatment Strategy.
Anticancer Res. 2024;44:3945-3954. PubMedAbstract available
August 2024
KAMADA T, Furukawa K, Takahashi J, Aida T, et al Preoperative Vertebral Fracture: A Prognostic Factor in Stage I-III Colorectal
Cancer.
Anticancer Res. 2024;44:3533-3541. PubMedAbstract available
YOKOTA Y, Nozawa H, Sonoda H, Yokoyama Y, et al Indoleamine 2,3-Dioxygenase Inhibitor Suppresses Colon Cancer Cell Migration,
Invasion, and Epithelial-Mesenchymal Transition.
Anticancer Res. 2024;44:3337-3342. PubMedAbstract available
TSUJIO G, Fukuoka T, Sugimoto A, Yonemitsu K, et al The Efficacy of Chemical Bowel Preparation Against Incisional Surgical Site
Infection in Colorectal Cancer Surgery: A Propensity Score Matching Study.
Anticancer Res. 2024;44:3473-3480. PubMedAbstract available
FUKUDA J, Sudo T, Kikuchi M, Kawahara A, et al Identification of DNA Repair-related Genes as Biomarkers Reflecting MSI, TMB, and
TIL in Colorectal Cancer.
Anticancer Res. 2024;44:3567-3575. PubMedAbstract available
TAKAHASHI H, Kojima D, Wada H, Hanaoka K, et al A Bridge to Curative Surgery for Obstructive Colorectal Cancer: Self-expandable
Metallic Stent Versus Decompression Tube.
Anticancer Res. 2024;44:3427-3441. PubMedAbstract available
MUKOHYAMA J, Koizumi M, Yamashita K, Yoshimi A, et al Knockdown of CDX2 Induces microRNA-221 Up-regulation in Human Colon Cancer Cells.
Anticancer Res. 2024;44:3553-3556. PubMedAbstract available
July 2024
KOMORI K, Yoshida M, Tsukushi S, Kinoshita T, et al Combined Pubic Arch and Ischial Bone Resection for Metachronous and Frequent
Local Recurrences of Rectal Cancer.
Anticancer Res. 2024;44:3205-3211. PubMedAbstract available
LEE SH, Kim SA, Park SJ, Lee MY, et al NUAK2 Inhibitors, KHKI-01128 and KHKI-01215, Exhibit Potent Anticancer Activity
Against SW480 Colorectal Cancer Cells.
Anticancer Res. 2024;44:2909-2919. PubMedAbstract available
SHIOI I, Ogawa H, Naito R, Endo M, et al Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for
Colorectal Cancer.
Anticancer Res. 2024;44:3013-3023. PubMedAbstract available
TSUMURAYA H, Mimura K, Nakajima S, Hanayama H, et al Tumor Infiltrating Effector Regulatory T Cells Express VEGF Receptor 2 in
Patients With Colorectal Cancer.
Anticancer Res. 2024;44:2933-2941. PubMedAbstract available
KARLIKOVA M, Curillova M, Pecen L, Karnos V Jr, et al Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer
Biomarkers in Colorectal Cancer.
Anticancer Res. 2024;44:3105-3113. PubMedAbstract available
June 2024
MOON SU, Lee JH, Shah M, Yoon S, et al RRM2 Is a CTNNB1 Transport Regulator Promoting Colon Cancer Progression.
Anticancer Res. 2024;44:2471-2485. PubMedAbstract available
TOREN W, Sasor A, Ansari D, Andersson R, et al ARHGAP4 as a Prognostic Biomarker for Colon Liver Metastases After Surgical
Resection.
Anticancer Res. 2024;44:2597-2604. PubMedAbstract available
MATSUDA A, Yamada T, Takahashi G, Matsumoto S, et al Significance of Adjuvant Chemotherapy for Obstructive Colorectal Cancer After
Stent Placement: A Multicenter Retrospective Study.
Anticancer Res. 2024;44:2737-2745. PubMedAbstract available
LIM SC, Lee TB, Han SI Caffeic Acid Enhances Anticancer Drug-induced Apoptosis in Acid-adapted HCT116
Colon Cancer Cells.
Anticancer Res. 2024;44:2587-2595. PubMedAbstract available
May 2024
WAGNER D, Karitnig R, Wienerroither V, Hau HM, et al Sarcopenic Obesity Promotes Recurrence in Patients Undergoing Resection for
Colorectal Liver Metastases (CRLM).
Anticancer Res. 2024;44:2177-2183. PubMedAbstract available
April 2024
WU CC, Su CC, Chen YH, Hsu CW, et al Comparative Effectiveness of Adjuvant Therapy on Survival in Patients With
Metastatic Colorectal Cancer.
Anticancer Res. 2024;44:1619-1628. PubMedAbstract available
TANAKA H, Hayashi H, Tomita H, Tokumaru Y, et al Association of Preoperative and Postoperative Plasma Syndecan-1 and Colorectal
Cancer Outcome.
Anticancer Res. 2024;44:1611-1618. PubMedAbstract available
SHIRAISHI T, Tominaga T, Ono R, Noda K, et al Short- and Long-term Outcomes After Colonic Stent Insertion as a Bridge to
Surgery in Elderly Colorectal Cancer Patients.
Anticancer Res. 2024;44:1637-1643. PubMedAbstract available
SYRJANEN K, Eskelinen M, Meklin J, Hendolin P, et al Colorectal Cancer Screening by Fecal Immunochemical Tests (FIT): Considerations
on Sampling and Markers (Hb and Hb/Hp Complex) of Fecal Occult Blood (FOB).
Anticancer Res. 2024;44:1513-1523. PubMedAbstract available
BEPPU T, Yamamura K, Masuda T, Miyamoto H, et al High-risk Patients With Colorectal Liver Metastases Assessed by the Beppu Score
Can Have Excellent Survival Through Multidisciplinary Treatment Including Local
Ablation.
Anticancer Res. 2024;44:1533-1539. PubMedAbstract available
SATOYOSHI T, Hirohashi Y, Okuya K, Miyo M, et al CD8-positive T Cell Infiltration With Human Leukocyte Antigen Class 1 Expression
Predicts Patients With Stage IV Colorectal Cancer Survival.
Anticancer Res. 2024;44:1603-1610. PubMedAbstract available
AOYAMA T, Yukawa N, Saito A Clinical Impact of Nutrition and Inflammation Assessment Tools in Colorectal
Cancer Treatment.
Anticancer Res. 2024;44:1335-1351. PubMedAbstract available
March 2024
ZHENG W, Chen K, Lv Y, Lao W, et al Pyrvinium Pamoate Induces Cell Apoptosis and Autophagy in Colorectal Cancer.
Anticancer Res. 2024;44:1193-1199. PubMedAbstract available
EBATA Y, Nakanishi R, Tanaka Y, Kawazoe T, et al Neoadjuvant Chemotherapy in Patients With T4b or Obstructive Colon Cancer: A
Single Center Retrospective Cohort Study.
Anticancer Res. 2024;44:1281-1287. PubMedAbstract available
HARA S, Sakai D, Ikemura K, Shintani T, et al Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil
Regimen in Patients With Colorectal Cancer.
Anticancer Res. 2024;44:1219-1226. PubMedAbstract available
SILVA EF, Fernandes BN, Marinello P, Deminice R, et al Pre and Post-high-intensity Interval Training Delays Colon Tumor Onset in a
Syngeneic Mouse Model.
Anticancer Res. 2024;44:1209-1217. PubMedAbstract available
HEGEDUS D, Szemeredi N, Gabor M, Sas J, et al Cyclic Amines Coupled to Indole Derivatives With Improved Efflux Pump Inhibiting
Activity in Bacteria and Cancer Cells.
Anticancer Res. 2024;44:1149-1160. PubMedAbstract available
ARDJMAND D, Kubota Y, Sato M, Han Q, et al Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells
Compared to Normal Cells.
Anticancer Res. 2024;44:929-933. PubMedAbstract available